The role of moderate to vigorous physical activity level and number of treatments/medications in mediating the effect of body mass index on diabetic nephropathy: a Mendelian randomization study.

Shasha Hu, Yuling Chen, Mingjie He, Jun Wen, Aimin Zhong, Dandan Zhan, Zhibin Ye
Author Information
  1. Shasha Hu: Department of Nephrology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
  2. Yuling Chen: Department of Nephrology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
  3. Mingjie He: Department of Nephrology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
  4. Jun Wen: Department of Nephrology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
  5. Aimin Zhong: Department of Nephrology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
  6. Dandan Zhan: Department of Nephrology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
  7. Zhibin Ye: Department of Nephrology, Huadong Hospital affiliated to Fudan University, Shanghai, China.

Abstract

BACKGROUND: Body mass index (BMI) is associated with diabetic nephropathy (DN). However, the mediator factors in the BMI-DN effects remain unclear.
METHODS: Univariate and multivariate Mendelian randomization (MR) analysis were performed to estimate the association between six lifestyles (moderate to vigorous physical activity levels, years of schooling, BMI, nap during day, number of treatments/medications taken and coffee intake) and DN. MR Egger, Weighted median, Simple mode, and Weighted mode was supplemental methods to Inverse variance weighted. Sensitivity analysis included heterogeneity test, horizontal pleiotropy test, and Leave-One-Out. Additionally, mediation MR was conducted to evaluate the mediating role of lifestyles between BMI and DN. Finally, functional enrichment analysis based on the mediation MR results was performed.
RESULTS: univariate and multivariate Mendelian randomization (MR) analysis were performed to estimate the association between six lifestyles (moderate to vigorous physical activity levels, years of schooling, BMI, nap during day, number of treatments/medications taken and coffee intake) and DN. MR Egger, Weighted median, Simple mode, and Weighted mode was supplemental methods to Inverse variance weighted. Sensitivity analysis included heterogeneity test, horizontal pleiotropy test, and Leave-One-Out. Additionally, mediation MR was conducted to evaluate the mediating role of lifestyles between BMI and DN. Finally, functional enrichment analysis based on the mediation MR results was performed.
CONCLUSION: our results supported mediation role of vigorous physical activity level and number of treatments/medications in BMI-DN effects.

Keywords

References

  1. Innovation (Camb). 2021 Jul 01;2(3):100141 [PMID: 34557778]
  2. Int J Epidemiol. 2012 Feb;41(1):161-76 [PMID: 22422451]
  3. Int J Epidemiol. 2015 Apr;44(2):484-95 [PMID: 25150977]
  4. Eur J Epidemiol. 2015 Jul;30(7):543-52 [PMID: 25773750]
  5. Medicine (Baltimore). 2014 Aug;93(7):e41 [PMID: 25101985]
  6. Annu Rev Public Health. 2016;37:17-32 [PMID: 26653405]
  7. BMC Med Genomics. 2023 Jun 15;16(1):132 [PMID: 37322504]
  8. J Immunol Res. 2021 Jun 21;2021:1893882 [PMID: 34239941]
  9. Nat Med. 2011 Feb;17(2):179-88 [PMID: 21217695]
  10. Front Endocrinol (Lausanne). 2023 Sep 14;14:1285535 [PMID: 37780609]
  11. PLoS One. 2018 Jan 24;13(1):e0191496 [PMID: 29364972]
  12. JAMA. 2016 Aug 9;316(6):602-10 [PMID: 27532915]
  13. Clin Sci (Lond). 2013 Feb;124(3):139-52 [PMID: 23075333]
  14. Nephrol Dial Transplant. 2014 Jun;29(6):1127-33 [PMID: 24286976]
  15. Diabetes Care. 2015 Feb;38(2):308-15 [PMID: 25510400]
  16. Genet Epidemiol. 2016 May;40(4):304-14 [PMID: 27061298]
  17. Kidney Int. 2015 Aug;88(2):286-98 [PMID: 25945408]
  18. Trends Endocrinol Metab. 2010 Jun;21(6):345-52 [PMID: 20223680]
  19. Sci Rep. 2016 Jun 07;6:27192 [PMID: 27273361]
  20. BMJ. 2022 Dec 7;379:e072385 [PMID: 36740855]
  21. Int J Epidemiol. 2017 Dec 1;46(6):1985-1998 [PMID: 29040600]
  22. Elife. 2018 May 30;7: [PMID: 29846171]
  23. Front Vet Sci. 2023 Dec 05;10:1274786 [PMID: 38116513]
  24. J Am Soc Nephrol. 2013 Feb;24(2):302-8 [PMID: 23362314]
  25. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045 [PMID: 28522654]
  26. Int J Epidemiol. 2015 Apr;44(2):512-25 [PMID: 26050253]
  27. Diabetologia. 2021 Apr;64(4):814-825 [PMID: 33452586]
  28. Front Endocrinol (Lausanne). 2024 Feb 08;15:1285872 [PMID: 38390197]
  29. Front Genet. 2022 Sep 29;13:872962 [PMID: 36246637]
  30. Stat Med. 2008 Apr 15;27(8):1133-63 [PMID: 17886233]
  31. Front Endocrinol (Lausanne). 2023 Oct 26;14:1278665 [PMID: 37964958]
  32. J Sports Sci. 2022 Mar;40(6):614-620 [PMID: 34818995]
  33. Med Sci Monit. 2019 Apr 25;25:3061-3068 [PMID: 31022160]
  34. PLoS Med. 2023 Jan 10;20(1):e1004135 [PMID: 36626356]
  35. Nephrol Dial Transplant. 2016 Feb;31(2):206-13 [PMID: 25550448]
  36. Lancet Diabetes Endocrinol. 2014 Oct;2(10):801-9 [PMID: 25127483]
  37. Cardiovasc Res. 2022 Dec 9;118(15):3151-3161 [PMID: 34893803]
  38. Hum Mol Genet. 2016 Oct 1;25(R2):R149-R156 [PMID: 27439390]
  39. Praxis (Bern 1994). 2018 Aug;107(17-18):971-976 [PMID: 30131033]
  40. Nephrol Dial Transplant. 2010 May;25(5):1394-8 [PMID: 20190244]

MeSH Term

Humans
Mendelian Randomization Analysis
Body Mass Index
Diabetic Nephropathies
Exercise
Risk Factors
Life Style

Word Cloud

Created with Highcharts 10.0.0MRanalysismediationBMIDNMendelianrandomizationperformedlifestylesvigorousphysicalactivitynumbertreatments/medicationsWeightedmodetestrolemassindexdiabeticmoderatemediatingresultsBodynephropathyBMI-DNeffectsmultivariateestimateassociationsixlevelsyearsschoolingnapdaytakencoffeeintakeEggermedianSimplesupplementalmethodsInversevarianceweightedSensitivityincludedheterogeneityhorizontalpleiotropyLeave-One-OutAdditionallyconductedevaluateFinallyfunctionalenrichmentbasedleveleffectBACKGROUND:associatedHowevermediatorfactorsremainunclearMETHODS:UnivariateRESULTS:univariateCONCLUSION:supportedbodynephropathy:studytype2diabetes

Similar Articles

Cited By